All Blogs & News

In this issue: Breaking news! First CRISPR-based therapy approved by the FDA for treatment of a genetic blood disorder - sickle cell...

After the successful launch of the mouse model project last year and advancing it to phase two this year, we have expanded our efforts to...

In this issue: IRDiRC Working Group Recommendations for rare disease patients; The Access to Rare Indications Act could be a game changer...